Genetic risk factors in patients with inflammatory bowel disease and vascular complications: Case-control study

Inflammatory Bowel Diseases

Volumn 13, Issue 4, 2007, Pages 410-415

  Koutroubakis, Ioannis E ^a   Sfiridaki, A ^b   Tsiolakidou, G ^a   Theodoropoulou, A ^b   Livadiotaki, A ^b   Paspatis, G ^b   Kouroumalis, E A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Venizelion General Hospital   (Greece)

Author keywords

Crohn's disease; Factor V Leiden; Genetics; PAI 1; Thrombosis; Ulcerative colitis

Indexed keywords

BLOOD CLOTTING FACTOR 5; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOSIS;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREECE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34247552113     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20076     Document Type: Article

References (30)

1. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61:140-145.
2. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97-101.
3. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430-434.
4. Koutroubakis IE. Vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:266-272.
5. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel diseasean independent and disease-specific risk factor for thromboembolism? Gut. 2004;53:542-548.
6. Hatoum O, Binion D. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis. 2005;11:304-313.
7. Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut. 2003;52:1435-1441.
8. Koutroubakis IE, Theodoropoulou A, Xydakis K, et al. Association between enhanced soluble CD40L and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:1147-1152.
9. Papa A, Santoliquido A, Danese S, et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;22:839-46.
10. Levy PJ, Tabares AH, Olin JW. Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. Am J Gastroenterol. 1997;92:494-497.
11. Crawford DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet. 2005;6:287-312.
12. Cambien F, Tiret L. Atherosclerosis: from genetic polymorphisms to system genetics. Cardiovasc Toxicol. 2005;5:143-152.
13. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24(Suppl):2-6.
14. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
15. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29-32.
16. Liebman HA, Kashani N, Sutherland D, et al. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology. 1998;115:830-834.
17. Guédon C, Le Cam-Duchez V, Lalaude O, et al. Prothrombotic inherited abnormalities other than factor V Leiden do not play a role in venous thrombosis in inflammatory Dowel disease. Am J Gastroenterol. 2001;96:1448-1454.
18. Papa A, De Stefano V, Gasparrini A, et al. Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coagul Fibrinolysis. 2000;11:499-503.
19. Koutroubakis I, Sfiridaki A, Mouzas I, et al. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2000;95:190-194.
20. Papa A, Danese S, Grillo A, et al. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1247-1251.
21. Caprini JA, Glase CJ, Anderson CB, et al. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;109(Suppl 1):4-8.
22. Koutroubakis IE, Tsiolakidou G, Kouroumalis EA. Inherited thrombophilia and thrombosis in inflammatory bowel disease. Am J Gastroenterol. 2006;101:403.
23. Spina L, Saibeni S, Battaglioli T, et al. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia. Am J Gastroenterol. 2005;100:2036-2041.
24. Dawson S, Hamsten A, Wiman B, et al. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991;11:183-190.
25. Eriksson P, Kallin B, Van't Hooft FM, et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA. 1995;92:1851-1855.
26. Tassies D, Espinosa G, Munoz-Rodriguez FJ, et al. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum. 2000;43:2349-2358.
27. Stegnar M, Uhrin P, Peternel P, et al. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost. 1998;79:975-979.
28. Magro F, Dinis-Ribeiro M, Araujo FM, et al. High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2003;15:1157-1163.
29. Vrij AA, Rijken J, van Wersch JWJ, et al. Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis. Pathophysiol Haemost Thromb. 2003;33:75-83.
30. Sans M, Tassies D, Pellise M, et al. The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease. Aliment Pharmacol Ther. 2003;17:1039-1047.